Sirolimus Coated Balloon for Arterial Disease Treatment

Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease

Recruiting N/A Interventional Study
Peripheral Artery Disease Atherosclerosis Arterial Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
21 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
279 (estimated)
Sponsor
Concept Medical Inc. · Industry
Who this trial is looking for

This trial is looking for adults with certain types of leg artery disease. Participants will receive treatment comparing a special drug-coated balloon with a standard balloon during a procedure for their condition.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 21 years old or older
  • I have leg artery disease classified as Rutherford class 3 to 6
  • I have arterial lesions between 2 to 20 cm in length
  • I have at least one non-occluded crural vessel leading to my foot
  • I have treated inflow lesions successfully if they were over 50% stenosis

You may not be able to join if

  • I have a life expectancy of 1 year or less
  • I am currently pregnant or planning to become pregnant
  • I have heel gangrene
  • I have had bypass surgery on the target vessel
  • I have a known allergy to sirolimus

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study aims to conduct a randomized, double blind, randomised controlled multicentre trial of sirolimus drug coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial and popliteal arterial disease.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age ≥ 21 years or minimum age 2. Rutherford class 3 to 6 in the target limb Intraoperative Inclusion Criteria 3. Single or sequential de novo or re-stenotic lesions (stenosis of \> 50% or occlusions) from 2 to 20cm in the femoropopliteal arteries. Lesion is considered as …
Contacts

Edward Choke

+65 69302164

tcchoke@hotmail.com

CONTACT